Refine
Has Fulltext
- yes (21)
Is part of the Bibliography
- yes (21)
Document Type
- Journal article (20)
- Preprint (1)
Language
- English (21)
Keywords
- positron emission tomography (6)
- CXCR4 (5)
- PRRT (5)
- multiple myeloma (5)
- PET/CT (4)
- PET (3)
- medicine (3)
- neuroendocrine tumor (3)
- theranostics (3)
- FDG (2)
- MAG3 (2)
- NET (2)
- PSMA (2)
- Positronen-Emissions-Tomografie (2)
- RADS (2)
- SSTR (2)
- SSTR-RADS (2)
- bone disease (2)
- chemokine receptor (2)
- lymphoma (2)
- molecular imaging (2)
- peptide receptor radionuclide therapy (2)
- prostate cancer (2)
- 177Lu (1)
- 18-F-fluorothymidine uptake (1)
- 68Ga-DOTANOC (1)
- 68Ga-DOTATATE (1)
- 68Ga-DOTATOC (1)
- Arginine (1)
- CXCR4/SDF-1 (1)
- CYP11B enzymes (1)
- DLBCL (1)
- DNA repair (1)
- DOTATOC (1)
- FDG PET/CT (1)
- FDG-PET (1)
- FLT-PET (1)
- Hyperkalaemia (1)
- Lysine (1)
- MI-RADS (1)
- Merkel cell carcinoma (1)
- Molecular imaging (1)
- NVP-BGT226 (1)
- PROMISE (1)
- PSMA-RADS (1)
- Parkinson’s disease (1)
- Positron emission tomography (1)
- Somatostatin receptor expression (1)
- [18F]Fluorodeoxythymidine (1)
- [\(^{68}\)Ga] pentixafor (1)
- [\(^{68}\)Ga]Pentixafor (1)
- \(^{11}\)C-Methionine-PET (1)
- \(^{11}\)C-methionine (1)
- \(^{18}\)F-FDG PET/CT (1)
- \(^{68}\)Ga-Pentixafor (1)
- adrenal incidentaloma (1)
- adrenocortical carcinoma (1)
- amino acids (1)
- autologous transplantation (1)
- cancer (1)
- cells (1)
- chemokine receptor-4 (1)
- cholinergic activity (1)
- early response (1)
- esophagogastric junction (1)
- experience (1)
- follicular lymphoma (1)
- glioblastoma (1)
- glioblastoma multiforme (1)
- glioma (1)
- hyperkalemia (1)
- imaging (1)
- imaging proliferation (1)
- imaging techniques (1)
- immunostaining (1)
- in vivo imaging (1)
- in-vivo (1)
- inhibition (1)
- involvement (1)
- kidney function (1)
- levodopa-induced dyskinesia (1)
- macrophages (1)
- magnetic resonance imaging (1)
- malignancies (1)
- mammalian target of rapamycin (1)
- management (1)
- microenvironment (1)
- microglial cells (1)
- neuroendocrine neoplasia (1)
- non-Hodgkin's lymphoma (1)
- non-hodgkins-lymphoma (1)
- phosphatidylinositol-3-kinase (1)
- pleural mesothelioma (1)
- positron emission tomography/computed tomography (1)
- prostate-specific membrane antigen (1)
- radionuclide therapy (1)
- recurrence (1)
- renal scintigraphy (1)
- reporting and data system (1)
- salvage radiotherapy (1)
- signaling pathway (1)
- somatostatin (1)
- somatostatin receptor (1)
- standardized reporting (1)
- stem-cell transplantation (1)
- survival (1)
- target (1)
- treatment response (1)
- tumor (1)
Institute
- Klinik und Poliklinik für Nuklearmedizin (21) (remove)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 701983 (2)
Background
Merkel cell carcinoma (MCC) is a rare cutaneous neoplasm with increasing incidence, aggressive behavior and poor prognosis. Somatostatin receptors (SSTR) are expressed in MCC and represent a potential target for both imaging and treatment.
Methods
To non-invasively assess SSTR expression in MCC using PET and the radiotracers [68Ga]DOTA-D-Phe1-Tyr3-octreotide (DOTATOC) or -octreotate (DOTATATE) as surrogate for tumor burden. In 24 patients with histologically proven MCC SSTR-PET was performed and compared to results of computed tomography (CT).
Results
SSTR-PET detected primary and metastatic MCC lesions. On a patient-based analysis, sensitivity of SSTR-PET was 73% for nodal metastases, 100% for bone, and 67% for soft-tissue metastases, respectively. Notably, brain metastases were initially detected by SSTR-PET in 2 patients, whereas liver and lung metastases were diagnosed exclusively by CT. SSTR-PET showed concordance to CT results in 20 out of 24 patients. Four patients (17%) were up-staged due to SSTR-PET and patient management was changed in 3 patients (13%).
Conclusion
SSTR-PET showed high sensitivity for imaging bone, soft tissue and brain metastases, and particularly in combination with CT had a significant impact on clinical stage and patient management.